HSBC Holdings’s Oramed Pharmaceuticals ORMP Stock Holding History

HSBC Holdings’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,000	Closed	-$100K	–	2129
2016 Q1	$100K	Hold	15,000	–	–	﹤0.01%	2016
2015 Q4	$128K	Hold	15,000	–	–	﹤0.01%	2135
2015 Q3	$82K	Hold	15,000	–	–	﹤0.01%	1880
2015 Q2	$85K	Hold	15,000	–	–	﹤0.01%	1938
2015 Q1	$96K	Hold	15,000	–	–	﹤0.01%	1992
2014 Q4	$68K	Hold	15,000	–	–	﹤0.01%	1748
2014 Q3	$121K	Hold	15,000	–	–	﹤0.01%	1694
2014 Q2	$144K	Hold	15,000	–	–	﹤0.01%	1710
2014 Q1	$174K	Buy	+15,000	New	+$253K	﹤0.01%	1657

Other funds holding ORMP

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

HSBC Holdings's ORMP Position: Q2 2016 in Review

HSBC Holdings sold out of Oramed Pharmaceuticals (ORMP) in Q2 2016, closing a stake of 15,000 shares — an estimated $100K sold.

HSBC Holdings first reported a position in ORMP in Q1 2014 and held it in 9 quarters. The position peaked at $174K in Q1 2014. 25 funds tracked by Wall St. Rank hold ORMP as of Q2 2016.

HSBC Holdings reported no remaining Oramed Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
HSBC Holdings sold 15,000 Oramed Pharmaceuticals shares in Q2 2016, an estimated $100K.
HSBC Holdings first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 9 quarters.
HSBC Holdings's Oramed Pharmaceuticals position peaked at $174K in Q1 2014.
25 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2016.

Based on HSBC Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.